Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications
The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The development of new therapies for treating various eye conditions has led to a demand for extended release delivery systems, which would lessen the need for frequent application while still achieving therapeutic drug levels in the target tissues. Areas covered: Following an overview of the different ocular drug delivery modalities, this article surveys the biomaterials used to develop sustained release drug delivery systems. Microspheres, nanospheres, liposomes, hydrogels, and composite systems are discussed in terms of their primary materials. The advantages and disadvantages of each drug delivery system are discussed for various applications. Recommendations for modifications and strategies for improvements to these basic systems are also discussed. Expert opinion: An ideal sustained release drug delivery system should be able to encapsulate and deliver the necessary drug to the target tissues at a therapeutic level without any detriment to the drug. Drug encapsulation should be as high as possible to minimize loss and unless it is specifically desired, the initial burst of drug release should be kept to a minimum. By modifying various biomaterials, it is possible to achieve sustained drug delivery to both the anterior and posterior segments of the eye.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retina can be accessed via three distinct routes: intravitreal, subretinal, and suprachoroidal (Figure 1) [14].”
From The Ocular Gene Delivery Landscape (2021) · cites this paper as [14]
Citations
Cites
Hydrogels for biomedical applications
Hoffman, A. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00239-3 · Cited by 4,864
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 4×
“This unique feature allows for the fabrication of a thermos-responsive hydrogel that remains in solution at low temperatures but becomes a gel-like consistency at body temperature [34].”
BackgroundInfluentialHydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
Peppas, N. A., Hilt, J. Z., Khademhosseini, A., & Langer, R. (2006) · Advanced Materials · doi:10.1002/adma.200501612 · Cited by 4,109
Hydrogels in pharmaceutical formulations
Peppas, N. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00090-4 · Cited by 4,011
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
The development of microgels/nanogels for drug delivery applications
Oh, J. K., Drumright, R., Siegwart, D. J., & Matyjaszewski, K. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.01.002 · Cited by 1,598
An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering
Gentile, P., Chiono, V., Carmagnola, I., & Hatton, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033640 · Cited by 1,593
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
PEG Hydrogels for the Controlled Release of Biomolecules in Regenerative Medicine
Lin, C.-C., & Anseth, K. S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9801-2 · Cited by 1,063
Research works printed but not linked: 9
- Ahmed I, 1985, Invest Ophthalmol Vis Sci, 26, 584
- Natarajan JV, 2012, Int J Nanomedicine, 7, 123
- Bressler NM, 2001, Arch Ophthalmol, 119, 198
- Kang-Mieler JJ, 2011, Duane’s Ophthalmol
- Hu C-C, 2014, Biomed Mater Eng, 24, 1941
- Drapala PW, 2010, J Biomat Sci Polym Edn
- Kang Derwent JJ, 2008, Trans Am Ophthalmol Soc, 106
- Moritera T, 1991, Invest Ophthalmol Vis Sci, 32, 1785
- Hughes PM, 2011, Intraocular pressure reduction with intracameral bimatoprost implants
Cited by
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
“Owing to the modification and fabrication of particle surfaces, compositions, polysaccharide mixtures, and ionic charges, these injected particles are distributed in the vitreous, enabling prolonged intravitreal half-lives by sustained drug release and delayed degradation and elimination [20,21].”
Polymer-based carriers for ophthalmic drug delivery
Imperiale, J. C., Acosta, G. B., & Sosnik, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.031 · Cited by 175
Intravitreal hydrogels for sustained release of therapeutic proteins
Ilochonwu, B. C., Urtti, A. O., Hennink, W. E., & Vermonden, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.031 · Cited by 164
Advances in ocular drug delivery systems
Kang‐Mieler, J. J., Rudeen, K. M., Liu, W., & Mieler, W. F. (2020) · Eye · doi:10.1038/s41433-020-0809-0 · Cited by 155
Self-citationNanoparticles in ocular applications and their potential toxicity
Cao, Y., Yang, J., Lu, A., Gong, J., Yang, Y., Lin, X., Li, M., & Xu, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.931759 · Cited by 119
Metadata
- Authors
- Kang-Mieler, J. J., Dosmar, E., Liu, W., & Mieler, W. F.
- Affiliations
- Illinois Institute of Technology (US)
- University of Illinois Chicago (US)
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2016-09
- Volume
- 14
- Issue
- 5
- Pages
- 611-620
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2513574704
- Cited by
- 73
- References
- 102
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 11 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 16 · 2019: 6 · 2018: 6 · 2017: 5 · 2016: 1
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Delivery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Ocular Surface and Contact Lens
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- ocular drug delivery, sustained drug release, biomaterials, microspheres, nanospheres, liposomes, hydrogels, anterior segment, posterior segment, burst release, drug encapsulation, ocular implants
- MeSH terms
- Biocompatible Materials, Delayed-Action Preparations, Eye, Eye Diseases, Humans, Liposomes, Microspheres, Drug Delivery Systems, Hydrogels, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications. https://app.cochat.ai/papers/10.1080/17425247.2016.1227785
- The paper
- Kang-Mieler, J. J., Dosmar, E., Liu, W., & Mieler, W. F. (2017). Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications. Expert Opinion on Drug Delivery. https://doi.org/10.1080/17425247.2016.1227785
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.